Amanta Healthcare Limited (NSE:AMANTA)

Market Cap	4.58B
Revenue (ttm)	2.88B +5.9%
Net Income	148.75M +41.7%
EPS	4.33 +16.7%
Shares Out	34.34M
PE Ratio	30.77
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	134,076
Open	129.15
Previous Close	132.27
Day's Range	129.15 - 134.41
52-Week Range	92.00 - 154.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About Amanta Healthcare

Amanta Healthcare Limited operates as a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products and parenteral products in Africa, Latin America, the United Kingdom, and internationally. The company manufactures its products in three product group segments Large Volume Parenteral, Nipple Head (Single Port), SteriPort (Two Ports), and Small Volume Parenteral. Additionally, it manufactures medical devices and fluid therapy - (IV Fluid), formulations, diluents, ophthalmic, respiratory ca...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 522
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AMANTA

Financial Performance

In fiscal year 2026, Amanta Healthcare's revenue was 2.91 billion, an increase of 5.95% compared to the previous year's 2.75 billion. Earnings were 148.75 million, an increase of 41.66%.